Items where the Funder is Merck

Number of items: 1.
1 May 2021
  • The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis. (2021) Phillips, Andrew N; Bansi-Matharu, Loveleen; Cambiano, Valentina; Ehrenkranz, Peter; Serenata, Celicia; Venter, Francois; Pett, Sarah; Flexner, Charles; Jahn, Andreas; Revill, Paul; Garnett, Geoff P